Oxidized LDL is the atherogenic form of LDL-cholesterol. It is a plaque-specific lipoprotein, found only in atherosclerotic plaques and not in normal artery walls. The conversion of LDL-cholesterol to oxidized LDL by reactive oxygen species (ROS; free radicals and peroxides) in the vascular endothelium is now widely recognized and accepted as a key biochemical reaction in the initiation and progression of the atherosclerotic disease process. Oxidized LDL is directly involved in all stages of the atherosclerotic disease process from the conversion of monocyte-macrophages into lipid-laden foam cells; from fatty streak formation to plaque formation; from plaque rupture and intra-arterial thrombosis to ischemia. The level of oxidized LDL found in the blood stream as a result of plaque formation feedback can differentiate between individuals with coronary artery disease from individuals who are “healthy” and not at risk, and can do so with a very high degree of accuracy.


A Proven and Simple Screening Test to accuratly detect CAD
Quest Ox-LDL.jpg
The Sun.jpg

New Publication for 2018

Contact US



National Screening Institute (NSI) has the exclusive world-wide rights to oxidized LDL and malondialdehyde (MDA)-modified LDL antibodies and corresponding technology developed by Professor Paul Holvoet at the University of Leuven, Belgium.